Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desloratadine in Japanese Subjects with Chronic Urticaria
NCT01916967Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Aug 2013
- Primary completion
- Feb 2014
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of desloratadine in chronic urticaria (CU), sponsored by Organon & Co.. Started Aug 2013; status: completed.
02
Drugs
desloratadine
03
Conditions
chronic urticaria (CU)
Beyond the preview
Go deeper on NCT01916967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01916967.